HLA-G and colorectal carcinoma: Furthermore, significantly higher sHLA-G were observed in the dead (46.8 U/ml, range: 3.3–531.0) than that in the alive CRC patients (27.4 U/ml, range: 1.6–511.4; p = 0.012; Figure 1).